Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE)

PLoS ONE

Volumn 12, Issue 5, 2017, Pages

  Al Badri, Ahmed ^a   Lai, Kha ^a   Wei, Janet ^a   Landes, Sofy ^a   Mehta, Puja K ^a   Li, Quanlin ^a   Johnson, Delia ^b   Reis, Steven E ^b   Kelsey, Sheryl F ^b   Bittner, Vera ^c   Sopko, George ^d   Shaw, Leslee J ^e   Pepine, Carl J ^f   Merz, C Noel Bairey ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c University of Alabama at Birmingham   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SERUM AMYLOID A;

ADULT; ARTICLE; CORONARY ARTERY OCCLUSION; CROSS-SECTIONAL STUDY; DISEASE ASSESSMENT; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PATHOGENESIS; PREDICTOR VARIABLE; PROTEIN BLOOD LEVEL; WOMEN'S HEALTH; COMPLICATION; HEART FAILURE; INFLAMMATION; METABOLISM; MYOCARDIAL ISCHEMIA; PROGNOSIS; UNITED STATES;

BIOMARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PROGNOSIS; UNITED STATES;

EID: 85019350582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0177684     Document Type: Article

References (30)

1. Marroquin OC, Kip KE, Mulukutla SR, Ridker PM, Pepine CJ, Tjandrawan T, et al. Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. American heart journal. 2005; 150(1):109-15. Epub 2005/08/09. https://doi.org/10.1016/j.ahj.2004.08.003 PMID: 16084156
2. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. The New England journal of medicine. 2004; 351(25):2599-610. Epub 2004/12/17. https://doi.org/10.1056/NEJMoa040967 PMID: 15602020
3. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Archives of internal medicine. 2009; 169(9):843-50. Epub 2009/05/13. PubMed Central PMCID: PMCPMC2782882. https://doi.org/10.1001/archinternmed.2009.50 PMID: 19433695
4. Bakir M, Nelson MD, Jones E, Li Q, Wei J, Sharif B, et al. Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study. International journal of cardiology. 2016; 223:936-9. Epub 2016/09/03. https://doi.org/10.1016/j.ijcard.2016.07.301 PMID: 27589041
5. Vilaro HT JR, cooper-DeHoff RM, HAndberg E, Sopko G, Kelsey S, Bairey Merz CN, Pepine CJ. Brachial Pulse Pressure Predicts Adverse Outcomes Including Heart Failure Hospitalizations in Women with Preserved Ejection Fraction and No Obstructive Coronary Artery Disease: A report from the Women's Ischimia Syndrome Evaluation. Circulation. 2014;2014; 130(A11580).
6. Wei J, Nelson MD, Szczepaniak EW, Smith L, Mehta PK, Thomson LE, et al. Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women. American journal of physiology Heart and circulatory physiology. 2016; 310(1):H14-9. Epub 2015/11/01. https://doi.org/10.1152/ajpheart.00612.2015 PMID: 26519031
7. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation. 2004; 109(6):726-32. Epub 2004/02/19. https://doi.org/10.1161/01.CIR.0000115516.54550.B1 PMID: 14970107
8. Kip KE, Marroquin OC, Shaw LJ, Arant CB, Wessel TR, Olson MB, et al. Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. American heart journal. 2005; 150(5):900-6. Epub 2005/11/18. https://doi.org/10.1016/j.ahj.2005.02.002 PMID: 16290958
9. Cosin-Sales J, Pizzi C, Brown S, Kaski JC. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. Journal of the American College of Cardiology. 2003; 41(9):1468-74. Epub 2003/05/14. PMID: 12742283
10. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. Journal of the American College of Cardiology. 1999; 33(6):1453-61. Epub 1999/05/20. PMID: 10334408
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3):499-511. Epub 2003/01/29. PMID: 12551878
12. Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet (London, England). 2001; 358(9275):24-9. Epub 2001/07/17.
13. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. The New England journal of medicine. 2000; 342(12):836-43. Epub 2000/03/25. https://doi.org/10.1056/NEJM200003233421202 PMID: 10733371
14. Vasan RS, Sullivan LM, Roubenoff R, Dinarello CA, Harris T, Benjamin EJ, et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003; 107(11):1486-91. Epub 2003/03/26. PMID: 12654604
15. Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiology in review. 2014; 22(3):147-51. Epub 2014/03/13. https://doi.org/10.1097/CRD.0000000000000021 PMID: 24618929
16. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr., Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. The New England journal of medicine. 2008; 359(21):2195-207. Epub 2008/11/11. https://doi.org/10.1056/NEJMoa0807646 PMID: 18997196
17. Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S. Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation. 2003; 108(17):2041-8. Epub 2003/10/29. https://doi.org/10.1161/01.CIR.0000089093.75585.98 PMID: 14581382
18. Shainkin-Kestenbaum R, Zimlichman S, Lis M, Lidor C, Pomerantz M, Knyszynski A, et al. Effect of serum amyloid A, HDL-apolipoprotein, on endothelial cell proliferation. Implication of an enigmatic protein to atherosclerosis. Biomedical peptides, proteins & nucleic acids: structure, synthesis & biological activity. 1996; 2(3):79-84. Epub 1996/01/01.
19. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation. 2003; 107(3):391-7. Epub 2003/01/29. PMID: 12551861
20. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obesity research. 2003; 11(9):1055-64. Epub 2003/09/16. https://doi.org/10.1038/oby.2003.145 PMID: 12972675
21. Imhof A, Froehlich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet (London, England). 2001; 357(9258):763-7. Epub 2001/03/20.
22. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002; 106(8):913-9. Epub 2002/08/21. PMID: 12186793
23. Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation. 2004; 109(17):2058-67. Epub 2004/04/14. https://doi.org/10.1161/01.CIR.0000127577.63323.24 PMID: 15078802
24. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000; 148(2):209-14. Epub 2000/02/05. PMID: 10657556
25. Zhang H, Wang HY, Bassel-Duby R, Maass DL, Johnston WE, Horton JW, et al. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. American journal of physiology Heart and circulatory physiology. 2007; 292(5):H2408-16. Epub 2007/01/16. https://doi.org/10.1152/ajpheart.01150.2006 PMID: 17220181
26. Wollert KC, Chien KR. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. Journal of molecular medicine (Berlin, Germany). 1997; 75(7):492-501. Epub 1997/07/01.
27. Hirota H, Yoshida K, Kishimoto T, Taga T. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proceedings of the National Academy of Sciences of the United States of America. 1995; 92(11):4862-6. Epub 1995/05/23. PubMed Central PMCID: PMCPMC41807. PMID: 7539136
28. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, Verbeken E, et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation. 2005; 111(8):996-1005. Epub 2005/02/16. https://doi.org/10.1161/01.CIR.0000156469.96135.0D PMID: 15710765
29. Yu XW, Liu MY, Kennedy RH, Liu SJ. Both cGMP and peroxynitrite mediate chronic interleukin-6-induced negative inotropy in adult rat ventricular myocytes. The Journal of physiology. 2005; 566(Pt 2):341-53. Epub 2005/05/10. PubMed Central PMCID: PMCPMC1464742. https://doi.org/10.1113/jphysiol.2005.087478 PMID: 15878941
30. Kristman V, Manno M, Cote P. Loss to follow-up in cohort studies: how much is too much? European journal of epidemiology. 2004; 19(8):751-60. Epub 2004/10/08. PMID: 15469032